Vascular Disrupting Agent BNC105P

A benzofuran-based vascular disrupting agent (VDA) prodrug with potential anti-vascular and antineoplastic activities. Upon administration vascular disrupting agent BNC105P, the disodium phosphate ester of BNC105, is rapidly converted to BNC105; in activated endothelial cells, BNC105 binds to tubulin and inhibits its polymerization, which may result in a blockage of mitotic spindle formation, cell cycle arrest, and disruption of the tumor vasculature. Hypoxic conditions ensue, depriving tumor cells of nutrients and resulting in tumor cell apoptosis. In addition to its VDA activity, this agent has a direct cytotoxic effect on tumor cells by inhibiting tubulin polymerization. BNC105 is not a substrate for the multidrug-resistance P-glycoprotein (Pgp) transporter. (NCI Thesaurus)

YOU MAY ALSO LIKE

Vascular Disorder

A non-neoplastic or neoplastic disorder affecting the arteries, veins, or lymphatic vessels. Examples include vasculitis, thrombophlebitis, arteriosclerosis, lymphedema, hemangioma, and angiosarcoma. …

Vascular Diseases

The vascular system is the body's network of blood vessels. It includes the arteries, veins and capillaries that carry blood to and…

Vascular Dementia

A degenerative vascular disorder affecting the brain. It is caused by the blockage of the blood supply to the brain. It is…

Vascular Cell Adhesion Molecule-1

Vascular cell adhesion molecule-1 (739 aa, ~81 kDa) is encoded by the human VCAM1 gene. This protein is involved in the adhesion…

Vascular Cell Adhesion Molecule 1 Measurement

The determination of the amount of vascular cell adhesion molecule 1 present in a sample.

Vascular cambium

The thin living sheath of meristematic tissue between the wood and the bark which differentiates into xylem on the inside and phloem…